Cornell Alison A

SEC Form 4 insider trading activity

Cornell Alison A has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jan 28, 2026.

On the most recent filing, Cornell Alison A is listed as Director at Zivo Bioscience, Inc. Inside the rolling window, Cornell Alison A reported 1 open-market purchase totaling $100K in ZIVO and no open-market sales.

Companies traded

Other insiders at ZIVO

Insider Buying

$100K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
ZIVO
Cornell Alison A
Purchase$100KJan 28SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Cornell Alison A made?

Cornell Alison A has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.

Which companies does Cornell Alison A trade?

Cornell Alison A has filed SEC Form 4 disclosures for 1 company, including ZIVO.

When was Cornell Alison A's most recent SEC Form 4 filing?

Cornell Alison A's most recent SEC Form 4 filing on Tracefour is dated Jan 28, 2026.

What is Cornell Alison A's total buy and sell value in the current window?

Inside the rolling retention window, Cornell Alison A bought $100K and sold $0 based on SEC Form 4 filings.

What was Cornell Alison A's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 11,709 ZIVO shares on 2026-01-26, worth $100K, per SEC Form 4 filings.